New Therapies in Outpatient Pulmonary Medicine.


Journal

The Medical clinics of North America
ISSN: 1557-9859
Titre abrégé: Med Clin North Am
Pays: United States
ID NLM: 2985236R

Informations de publication

Date de publication:
Sep 2024
Historique:
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 31 7 2024
Statut: ppublish

Résumé

Newer medications and devices, as well as greater understanding of the benefits and limitations of existing treatments, have led to expanded treatment options for patients with lung disease. Treatment advances have led to improved outcomes for patients with asthma, chronic obstructive pulmonary disease, interstitial lung disease, pulmonary hypertension, and cystic fibrosis. The risks and benefits of available treatments are substantially variable within these heterogeneous disease groups. Defining the role of newer therapies mandates both an understanding of these disorders and overall treatment approaches. This section will review general treatment approaches in addition to focusing on newer therapies for these conditions..

Identifiants

pubmed: 39084837
pii: S0025-7125(24)00036-1
doi: 10.1016/j.mcna.2024.03.011
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

843-869

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

Laura Granados (L)

Department of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA, USA. Electronic address: granal@uw.edu.

Mira John (M)

Department of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA, USA.

Jeffrey D Edelman (JD)

Department of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA, USA; Puget Sound Department of Veterans Affairs, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH